Company · CIK 0001598646 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Minerva Neurosciences, Inc. · NERV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 3, 2026 AForm 4 → | Aug 3, 6:05 pm EDT | Inderjit KaulDirector | 12,147 | — | — | 12,147 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | Frederick W AhlholmSVP, CFO and Secretary | 680,000 | — | — | 680,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | Remy LuthringerCEO, Director | 1,690,700 | — | — | 1,690,700 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | Fouzia Laghrissi-ThodeDirector | 50,000 | — | — | 50,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | David KupferDirector | 50,000 | — | — | 50,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | Inderjit KaulDirector | 50,000 | — | — | 50,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | G Jan Van HeekDirector | 50,000 | — | — | 50,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 5, 6:00 pm EDT | Hans Peter HaslerDirector | 50,000 | — | — | 50,000 | — |